NL-OMON28180招募中不适用
Identification of pediatric Hodgkin lymphoma biomarkers and novel therapeutic targets
Erasmus MC - Sophia0 个研究点目标入组 320 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Hodgkin lymphoma group
- •In order to be eligible to participate in the Hodgkin lymphoma group, a subject must meet all of the following criteria:
- •-? Diagnosis of classical Hodgkin Lymphoma confirmed by reference pathology
- •-? Patient aged below 18 at time of diagnosis
- •-? Treatment according the European Network of Paediatric Hodgkin`s Lymphoma Second International Inter-Group Study for Classical Hodgkin’s Lymphoma in Children and Adolescents (EuroNet-PHL-C2) protocol or treatment for relapsed or refractory patients.
- •-? Written informed consent of the patient and/or the patient's parents or guardians according to national laws
- •Control Group
- •In order to be eligible to participate in the control group a subject must meet all of the following criteria:
- •-? No diagnosis of classical Hodgkin Lymphoma confirmed by reference pathology
- •-? Patient aged below 18 at time of diagnosis
- •-? Written informed consent of the patient and/or the patient's parents or guardians according to national laws
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •-? HIV positivity
- •-? Other underlying immunologic disorders, with the exception of Epstein Barr Virus
研究者
相似试验
招募中
不适用
Identification of paediatric Hodgkin lymphoma biomarkers and novel therapeutic targets.Hodgkin disease10025319Hodgkin lymphomamalignant lymphomaNL-OMON54726Erasmus MC, Universitair Medisch Centrum Rotterdam230
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin?s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin?s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1EUCTR2007-004092-19-NLMartin Luther University of Halle/Wittenberg
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1The first line therapy for childhood nodular lymphocyte-predominant Hodgkin’s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.EUCTR2007-004092-19-CZMartin Luther University of Halle/Wittenberg250
进行中（未招募）
1 期
Evaluation of the therapy of Hodgkin’s Lymphoma in Children and AdolescentsEUCTR2007-004092-19-DEMartin Luther University of Halle/Wittenberg200
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1The first line therapy for childhood nodular lymphocyte-predominant Hodgkin’s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.EUCTR2007-004092-19-ATMartin Luther University of Halle/Wittenberg250